Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $18.1 million.

  • Atara Biotherapeutics' Total Current Liabilities fell 8842.34% to $18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year decrease of 8842.34%. This contributed to the annual value of $134.6 million for FY2024, which is 538.02% down from last year.
  • Atara Biotherapeutics' Total Current Liabilities amounted to $18.1 million in Q3 2025, which was down 8842.34% from $14.6 million recorded in Q2 2025.
  • In the past 5 years, Atara Biotherapeutics' Total Current Liabilities registered a high of $180.7 million during Q1 2024, and its lowest value of $14.6 million during Q2 2025.
  • Over the past 4 years, Atara Biotherapeutics' median Total Current Liabilities value was $78.9 million (recorded in 2022), while the average stood at $92.1 million.
  • Per our database at Business Quant, Atara Biotherapeutics' Total Current Liabilities soared by 16620.6% in 2024 and then tumbled by 9017.79% in 2025.
  • Atara Biotherapeutics' Total Current Liabilities (Quarter) stood at $78.9 million in 2022, then skyrocketed by 80.22% to $142.2 million in 2023, then decreased by 5.38% to $134.6 million in 2024, then tumbled by 86.58% to $18.1 million in 2025.
  • Its Total Current Liabilities was $18.1 million in Q3 2025, compared to $14.6 million in Q2 2025 and $47.9 million in Q1 2025.